Top

Published in:

04-02-2022 | Heart Transplantation

Evaluation of donor heart for transplantation

Authors: Robert Tatum, Alexandros Briasoulis, Vakhtang Tchantchaleishvili, H. Todd Massey

Published in: Heart Failure Reviews | Issue 5/2022

Abstract

Cardiac transplantation is considered the gold-standard treatment option for patients suffering from end-stage heart failure refractory to maximum medical therapy. A major determinant of graft function and recipient survival is a comprehensive evaluation of the donor allograft. Challenges arise when designing and implementing an evidence-based donor evaluation protocol due to the number of influential donor-specific characteristics and the complex interactions that occur between them. Here, we present our systematic approach to donor evaluation by examining the impact that relevant donor variables have on graft function and recipient outcomes.

Alraies MC, Eckman P (2014) Adult heart transplant: indications and outcomes. J Thorac Dis. https://doi.org/10.3978/j.issn.2072-1439.2014.06.44CrossRefPubMedPubMedCentral

Mancini D, Lietz K (2010) Selection of cardiac transplantation candidates in 2010. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.109.858076CrossRefPubMedPubMedCentral

Colvin-Adams M, Valapour M, Hertz M, Heubner B, Paulson K, Dhungel V, Skeans MA, Edwards L, Ghimire V, Waller C, Cherikh WS, Kasiske BL, Snyder JJ, Israni AK. Lung and heart allocation in the United States. Am J Transplant. 2012;12(12):3213-3234. https://doi.org/10.1111/j.1600-6143.2012.04258.x

Persad G, Wertheimer A, Emanuel EJ. Principles for allocation of scarce medical interventions. Lancet. 2009. https://doi.org/10.1016/S0140-6736(09)60137-9

Estep J, Soltesz E, Cogswell R. The new heart transplant allocation system: Early observations and mechanical circulatory support considerations. J Thorac Cardiovasc Surg. 2020;S0022-5223(20)32638-6. https://doi.org/10.1016/j.jtcvs.2020.08.113

Mullan CW, Sen S, Ahmad T. Left Ventricular Assist Devices Versus Heart Transplantation for End Stage Heart Failure is a Misleading Equivalency. JACC Hear Fail. 2021. https://doi.org/10.1016/j.jchf.2021.02.004

Latif F, Farr MA, Clerkin KJ, et al. Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.2159

Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match. J Hear Lung Transplant. 2019. https://doi.org/10.1016/j.healun.2019.08.004

Colvin MM, Cook JL, Chang PP, et al. Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. Circulation. 2019. https://doi.org/10.1161/CIR.0000000000000598

10.

Barten MJ, Schulz U, Beiras-Fernandez A, et al. The clinical impact of donor-specific antibodies in heart transplantation. Transplant Rev. 2018. https://doi.org/10.1016/j.trre.2018.05.002

11.

Deo S V., Al-Kindi SG, Altarabsheh SE, et al. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing. J Hear Lung Transplant. 2016. https://doi.org/10.1016/j.healun.2015.10.008

12.

Chih S, Patel J. Desensitization strategies in adult heart transplantation—Will persistence pay off? J Hear Lung Transplant. 2016. https://doi.org/10.1016/j.healun.2016.03.021

13.

Russo MJ, Chen JM, Sorabella RA, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: An analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg. 2007. https://doi.org/10.1016/j.jtcvs.2006.09.019

14.

Buendía-Fuentes F, Almenar-Bonet L, Martínez-Dolz L, et al. Ischemic Time as a Predictor of Physical Recovery in the First Months after Heart Transplantation. ISRN Cardiol. 2012. https://doi.org/10.5402/2012/907102

15.

Scheule AM, Zimmerman GJ, Johnston JK, Razzouk AJ, Gundry SR, Bailey LL. Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation. 2002. https://doi.org/10.1161/01.cir.0000032882.55215.00

16.

Chamogeorgakis T, Joseph S, Hall S, et al. Impact of donor age on cardiac transplantation outcomes and on cardiac function. Interact Cardiovasc Thorac Surg. 2016. https://doi.org/10.1093/icvts/ivw172

17.

Sorabella RA, Guglielmetti L, Kantor A, et al. Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database. Transplant Proc. 2015. https://doi.org/10.1016/j.transproceed.2015.10.021

18.

Gupta D, Piacentino V, MacHa M, et al. Effect of older donor age on risk for mortality after heart transplantation. Ann Thorac Surg. 2004. https://doi.org/10.1016/j.athoracsur.2004.02.016

19.

Ram E, Lavee J, Kogan A, et al. Does donor-recipient age difference matter in outcome of heart transplantation? Clin Transplant. 2019. https://doi.org/10.1111/ctr.13593

20.

Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction after Cardiac Transplantation (IMPACT) using international registry data. J Hear Lung Transplant. 2013. https://doi.org/10.1016/j.healun.2013.02.001

21.

Singhal AK, Sheng X, Drakos SG, Stehlik J. Impact of Donor Cause of Death on Transplant Outcomes: UNOS Registry Analysis. Transplant Proc. 2009. https://doi.org/10.1016/j.transproceed.2009.06.192

22.

Martìn-Suàrez S, Mikus E, Pilato E, et al. Cardiac Transplantation From a Carbon Monoxide Intoxicated Donor. Transplant Proc. 2008. https://doi.org/10.1016/j.transproceed.2008.03.155

23.

Cohen O, De La Zerda DJ, Beygui R, Hekmat D, Laks H. Donor Brain Death Mechanisms and Outcomes After Heart Transplantation. Transplant Proc. 2007. https://doi.org/10.1016/j.transproceed.2007.08.102

24.

Guzman JA. Carbon Monoxide Poisoning. Crit Care Clin. 2012. https://doi.org/10.1016/j.ccc.2012.07.007

25.

Altshuler PJ, Helmers MR, Atluri P. Organ allocation and procurement in cardiac transplantation. Curr Opin Organ Transplant. 2021. https://doi.org/10.1097/MOT.0000000000000872

26.

Phillips KG, Ranganath NK, Malas J, et al. Impact of the Opioid Epidemic on Heart Transplantation: Donor Characteristics and Organ Discard. Ann Thorac Surg. 2019. https://doi.org/10.1016/j.athoracsur.2019.03.076

27.

Guihaire J, Noly PE, Martin A, et al. Impact of donor comorbidities on heart transplant outcomes in the modern era. Interact Cardiovasc Thorac Surg. 2017. https://doi.org/10.1093/icvts/ivx014

28.

Taghavi S, Jayarajan SN, Wilson LM, Komaroff E, Testani JM, Mangi AA. Cardiac transplantation can be safely performed using selected diabetic donors. J Thorac Cardiovasc Surg. 2013. https://doi.org/10.1016/j.jtcvs.2013.02.047

29.

Huang S, Tang Y, Zhu Z, et al. Outcomes of organ transplantation from donors with a cancer history. Med Sci Monit. 2018. https://doi.org/10.12659/MSM.909059

30.

Kimura Y, Seguchi O, Iwasaki K, et al. Impact of coronary artery calcification in the donor heart on transmitted coronary artery disease in heart transplant recipients. Circ J. 2018. https://doi.org/10.1253/circj.CJ-18-0107

31.

Ziaziaris W, Chew HC, Dhital K, Hayward C, Pleass H, Macdonald P. Size and Gender Matching in Heart Transplantation – Optimizing Donor Utilization in an Era of Changing Donor and Recipient Characteristics. Curr Transplant Reports. 2014. https://doi.org/10.1007/s40472-014-0032-7

32.

Reed RM, Netzer G, Hunsicker L, et al. Cardiac Size and Sex-Matching in Heart Transplantation: Size Matters in Matters of Sex and the Heart. JACC Hear Fail. 2014. https://doi.org/10.1016/j.jchf.2013.09.005

33.

Tremblay-Gravel M, Khush K. Predicted Heart Mass for Donor Organ Allocation. Circ Hear Fail. 2019. https://doi.org/10.1161/circheartfailure.119.006634

34.

Cheshire C, Kydd A, Nerlekar N, et al. Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort? Clin Transplant. 2021. https://doi.org/10.1111/ctr.14192

35.

Costanzo MR, Dipchand A, Starling R, et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Hear Lung Transplant. 2010. https://doi.org/10.1016/j.healun.2010.05.034

36.

Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant. 2009. https://doi.org/10.1111/j.1600-6143.2009.02888.x

37.

Sukhavasi A, Weber MP, Maynes EJ, Brailovsky Y, Shah MK, Rajapreyar I, Alvarez RJ, Rame JE, Entwistle JW, Massey HT, Tchantchaleishvili V. Utility of Recipient Cardiothoracic Ratio in Predicting Delayed Chest Closure after Heart Transplantation. International Society for Heart and Lung Transplantation 41st Annual Meeting and Scientific Sessions. 2021.

38.

Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011. https://doi.org/10.1111/j.1600-6143.2011.03493.x

39.

White SL, Rawlinson W, Boan P, et al. Infectious disease transmission in solid organ transplantation: Donor evaluation, recipient risk, and outcomes of transmission. Transplant Direct. 2019. https://doi.org/10.1097/TXD.0000000000000852

40.

Dorent R, Gandjbakhch E, Goéminne C, et al. Assessment of potential heart donors: A statement from the French heart transplant community. Arch Cardiovasc Dis. 2018. https://doi.org/10.1016/j.acvd.2017.12.001

41.

Westphal GA, Garcia VD, De Souza RL, et al. Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva. 2016. https://doi.org/10.5935/0103-507X.20160049

42.

Botha J, Fabian J, Etheredge H, Conradie F, Tiemessen CT (2019) HIV and solid organ transplantation: where are we now. Curr HIV/AIDS Rep. https://doi.org/10.1007/s11904-019-00460-7CrossRefPubMedPubMedCentral

43.

Blumberg EA. Organs from Hepatitis C Virus–Positive Donors. N Engl J Med. 2019. https://doi.org/10.1056/nejme1901957

44.

Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: Consensus guidelines for recipient management. Am J Transplant. 2015. https://doi.org/10.1111/ajt.13187

45.

Shah MB, Lynch RJ, El-Haddad H, Doby B, Brockmeier D, Goldberg DS. Utilization of deceased donors during a pandemic: argument against using SARS-CoV-2–positive donors. Am J Transplant. 2020. https://doi.org/10.1111/ajt.15969

46.

NasrAllah MM, Osman NA, Elalfy M, Malvezzi P, Rostaing L. Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? Rev Med Virol. 2021. https://doi.org/10.1002/rmv.2149

47.

Weiss MJ, Lalani J, Patriquin-Stoner C, et al. Summary of International Recommendations for Donation and Transplantation Programs during the Coronavirus Disease Pandemic. Transplantation. 2021. https://doi.org/10.1097/TP.0000000000003520

48.

Watson CJ, Roberts R, Wright KA, Greenberg DC, Rous BA, Brown CH, Counter C, Collett D, Bradley JA. How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant. 2010;10(6):1437-44. https://doi.org/10.1111/j.1600-6143.2010.03130.x

49.

Tanim Anwar ASM, Lee JM. Medical management of brain-dead organ donors. Acute Crit Care. 2019. https://doi.org/10.4266/acc.2019.00430

50.

Kotloff RM, Blosser S, Fulda GJ, et al. Management of the Potential Organ Donor in the ICU. Crit Care Med. 2015. https://doi.org/10.1097/ccm.0000000000000958

51.

Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002;2(8):701-11. https://doi.org/10.1034/j.1600-6143.2002.20804.x

52.

Yang HY, Lin CY, Tsai YT, Lee CY, Tsai CS. Experience of heart transplantation from hemodynamically unstable brain-dead donors with extracorporeal support. Clin Transplant. 2012. https://doi.org/10.1111/j.1399-0012.2011.01585.x

53.

Potapov EV, Ivanitskaia EA, Loebe M, et al. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation. 2001. https://doi.org/10.1097/00007890-200105270-00007

54.

Madan S, Saeed O, Shin J, et al. Donor Troponin and Survival after Cardiac Transplantation: An Analysis of the United Network of Organ Sharing Registry. Circ Hear Fail. 2016. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002909

55.

Vorlat A, Conraads VM, Jorens PG, et al. Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation. J Hear Lung Transplant. 2012. https://doi.org/10.1016/j.healun.2012.02.009

56.

Chen CW, Sprys MH, Gaffey AC, et al. Low ejection fraction in donor hearts is not directly associated with increased recipient mortality. J Hear Lung Transplant. 2017. https://doi.org/10.1016/j.healun.2017.02.001

57.

Forni A, Luciani GB, Chiominto B, Pilati M, Mazzucco A, Faggian G. Impact of donor quality on outcome of heart transplantation. Eur J Cardio-thoracic Surg. 2010. https://doi.org/10.1016/j.ejcts.2010.03.042

58.

Stoica SC, Satchithananda DK, Charman S, et al. Swan-Ganz catheter assessment of donor hearts: Outcome of organs with borderline hemodynamics. J Hear Lung Transplant. 2002. https://doi.org/10.1016/S1053-2498(02)00380-7

59.

Bona M, Wyss RK, Arnold M, et al. Cardiac graft assessment in the era of machine perfusion: Current and future biomarkers. J Am Heart Assoc. 2021. https://doi.org/10.1161/JAHA.120.018966

60.

Ribeiro RVP, Alvarez JS, Yu F, et al. Comparing Donor Heart Assessment Strategies during Ex Situ Heart Perfusion to Better Estimate Posttransplant Cardiac Function. Transplantation. 2020. https://doi.org/10.1097/TP.0000000000003374

61.

Claes S, Berchtold-Herz M, Zhou Q, et al. Towards a cardiac allocation score: A retrospective calculation for 73 patients from a German transplant center. J Cardiothorac Surg. 2017. https://doi.org/10.1186/s13019-017-0575-7

62.

Kohli K, Kovács SJ. The quest for load-independent left ventricular chamber properties: exploring the normalized pressure–volume loop. Physiol Rep. 2017. https://doi.org/10.14814/phy2.13160

63.

Wang Y, Zhang R, Huang Y, et al. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients. Clin Chim Acta. 2019. https://doi.org/10.1016/j.cca.2018.12.025

64.

Zahavi G, Frogel J, Shlomo N, Klempfner R, Unger R. Machine learning models predict 30-day and 1-year mortality in heart failure. J Am Coll Cardiol. 2020. https://doi.org/10.1016/s0735-1097(20)31485-6

Title: Evaluation of donor heart for transplantation
Authors: Robert Tatum
Alexandros Briasoulis
Vakhtang Tchantchaleishvili
H. Todd Massey
Publication date: 04-02-2022
Publisher: Springer US
Keywords: Heart Transplantation
Heart Transplantation
Heart Transplantation
Heart Transplantation
Heart Transplantation
Published in: Heart Failure Reviews / Issue 5/2022
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-021-10178-7

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation of donor heart for transplantation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2022

99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions

ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study

Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution

Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program

The role of lymphangiogenesis in cardiovascular diseases and heart transplantation

Prognostic value of non-contrast myocardial T1 mapping in cardiovascular diseases: a systematic review and meta-analysis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page